Aspirin helps survival from colorectal cancer
A team at Massachusetts General Hospital and Harvard Medical School has shown that aspirin also helps survival in patients who have already got colorectal cancer and, indeed, also reduces overall mortality.
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.